Timing of Surgery After an Acute Coronary Syndrome
A 63-year-old man is listed for elective laparoscopic cholecystectomy for recurrent biliary colic. Six weeks ago he was admitted with an ST-elevation myocardial infarction and underwent percutaneous coronary intervention with a drug-eluting stent to the left anterior descending artery. He is now asymptomatic, back to normal activities, and keen to 'get the gallbladder done' because the attacks are frequent and painful. His medications are aspirin, ticagrelor, atorvastatin, bisoprolol and ramipril. Echocardiography showed an ejection fraction of 45%. He asks whether he can stop the ticagrelor around the operation so the surgery can go ahead next week.
1. What are the competing risks, and how do they shape the timing decision?
Read the worked answer
There are two opposing hazards:
- Bleeding risk if surgery proceeds while he is on dual antiplatelet therapy (DAPT) - aspirin plus ticagrelor - particularly with a recently placed drug-eluting stent.
- Stent thrombosis and recurrent ischaemic risk if antiplatelet therapy is interrupted, especially early after PCI and in a recently stented LAD. Premature discontinuation of DAPT is a major cause of stent thrombosis, which carries high mortality.
Guidelines generally advise deferring elective non-cardiac surgery for at least 6 months after elective PCI with a drug-eluting stent (and longer - up to 12 months - where the ischaemic risk is high, as with a recent STEMI and a proximal LAD stent). At six weeks he is well inside the highest-risk window.
The judgement: do not rush to operate next week. The correct move is to defer the elective cholecystectomy until the stent-protection window has passed, in consultation with cardiology, while managing his biliary symptoms medically in the interim.
2. How would you respond to his request to stop ticagrelor so surgery can proceed?
Read the worked answer
I would explain clearly that stopping ticagrelor now is the dangerous option, not the safe one. Interrupting DAPT six weeks after a STEMI and LAD stenting risks stent thrombosis, which can be fatal - a far greater threat than a delayed gallbladder operation.
I would:
- Validate his frustration - frequent biliary colic is genuinely unpleasant - and explain that the plan is to delay, not cancel.
- Explain the reasoning in plain terms: the stent needs time to endothelialise and the heart needs time to recover; operating too early trades a small operative risk for a large cardiac one.
- Set a realistic timeline (typically deferring until at least 6 months post-PCI, with cardiology input on the exact date and on whether ticagrelor can be transitioned to aspirin monotherapy nearer the time).
- Agree a bridging plan: dietary advice, analgesia, and clear instructions to present acutely if he develops fever, jaundice, or prolonged severe pain - in which case emergency surgery would be reconsidered with a different risk balance.
3. If he returns in the interim with acute cholecystitis, how does your approach change?
Read the worked answer
An emergency changes the calculus: the risk of untreated acute cholecystitis (perforation, sepsis) may now outweigh the cardiac risk of operating during the stent-protection window. The decision becomes a multidisciplinary one involving cardiology, anaesthesia, and surgery.
Options:
- Operative management with careful perioperative planning: involve cardiology on antiplatelet management (often continuing aspirin, with a considered decision on ticagrelor balancing bleeding against stent risk), optimise the patient, and use a minimally invasive approach where feasible.
- Non-operative/damage-control management if operative risk is judged prohibitive: intravenous antibiotics, analgesia, and consideration of percutaneous cholecystostomy to drain the septic focus, deferring cholecystectomy until the cardiac risk window has passed.
The key judgement is that the earlier decision to defer was correct for an elective situation, but it must be revisited, not rigidly applied, when the clinical picture changes - and the final call should be shared and documented rather than made by one team in isolation.